NIH-funded research U01 cooperative agreement

Protecting kidney health in children with spina bifida

Official title: Research Approaches to Improve the Care and Outcomes of People Living with Spina Bifida- Component C

Funded at University of Alabama at Birmingham · NIH-11422051 · Data updated 2026-11-12

This project is trying a standard urology care plan to protect kidneys in newborns and young children born with spina bifida.

More Spina Bifida research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startSeptember 1, 2019
Project endAugust 31, 2026
Funding year2023
Award (this year)$25,000
NIH project number6U01DD001236-05M002
Project IDNIH-11422051 on NIH RePORTER

Who could benefit from this research

Could help

Newborns and children with spina bifida who have a neurogenic bladder, especially those from birth up to age 10 and willing to follow a standardized urologic care plan, are ideal candidates.

Less likely to help

Adults with spina bifida, children older than 10, or patients who already have advanced kidney damage are unlikely to benefit from this early-life prevention protocol.

What this research studies

You and your child would follow the UMPIRE care protocol from birth through age 10 to try to prevent kidney damage from a neurogenic bladder. Care includes scheduled bladder monitoring, imaging and kidney function tests, and standard treatments such as catheterization and medications when needed. The team will track kidney health, bladder outcomes, and resource use to see if the protocol preserves normal kidney function while using resources efficiently. This work continues earlier follow-up through age 5 to confirm longer-term benefits up to age 10.

Why it matters

Potential benefit: If successful, the UMPIRE protocol could keep more children’s kidneys healthy and reduce costly complications and surgeries.

How similar studies have gone: Prior funding established the UMPIRE protocol and early follow-up through age 5 showed promise, but effectiveness through age 10 is still being confirmed.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Joseph, David B — University of Alabama at Birmingham
  • Study coordinator: Joseph, David B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.